PROFERDEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Proferdex, and when can generic versions of Proferdex launch?
Proferdex is a drug marketed by New River and is included in one NDA.
The generic ingredient in PROFERDEX is ferric oxyhydroxide. There are twenty drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the ferric oxyhydroxide profile page.
Summary for PROFERDEX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 33 |
DailyMed Link: | PROFERDEX at DailyMed |
US Patents and Regulatory Information for PROFERDEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
New River | PROFERDEX | ferric oxyhydroxide | INJECTABLE;INJECTION | 017807-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |